LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Article ; Online: COVID-19 in Hemodialysis Patients: A Report of 5 Cases.

    Wang, Rui / Liao, Cong / He, Hong / Hu, Chun / Wei, Zimeng / Hong, Zixi / Zhang, Chengjie / Liao, Meiyan / Shui, Hua

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2020  Volume 76, Issue 1, Page(s) 141–143

    Abstract: ... University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 ... features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan ... patients with COVID-19 infection, one had a definite history of contact with an infected person. The age ...

    Abstract In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this case report, we describe the clinical and epidemiologic features of COVID-19 infection in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan University, including 5 maintenance hemodialysis patients who contracted COVID-19 infection. Of the 5 patients with COVID-19 infection, one had a definite history of contact with an infected person. The age range of the patients was 47 to 67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients. Computed tomography of the chest showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, or multiple organ dysfunction) or died.
    MeSH term(s) Aged ; Betacoronavirus ; COVID-19 ; China/epidemiology ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Disease Outbreaks ; Female ; Humans ; Kidney Failure, Chronic/etiology ; Kidney Failure, Chronic/therapy ; Lung/diagnostic imaging ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Renal Dialysis/methods ; SARS-CoV-2 ; Tomography, X-Ray Computed ; Treatment Outcome
    Keywords covid19
    Language English
    Publishing date 2020-03-31
    Publishing country United States
    Document type Case Reports
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2020.03.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: COVID-19 in Hemodialysis Patients: A Report of 5 Cases

    Wang, Rui / Liao, Cong / He, Hong / Hu, Chun / Wei, Zimeng / Hong, Zixi / Zhang, Chengjie / Liao, Meiyan / Shui, Hua

    American Journal of Kidney Diseases

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #638794
    Database COVID19

    Kategorien

  3. Article: Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review.

    He, Yan-Fei / Ouyang, Jing / Hu, Xiao-Dong / Wu, Ni / Jiang, Zhi-Gang / Bian, Ning / Wang, Jie

    World journal of diabetes

    2023  Volume 14, Issue 6, Page(s) 892–918

    Abstract: ... does vaccination against COVID-19 exacerbate the severity of pre-existing diseases in patients ... Background: Coronavirus disease 2019 (COVID-19) is one of the current global public health threats ... and vaccination is the most effective tool to reduce the spread and decrease the severity of COVID-19 ...

    Abstract Background: Coronavirus disease 2019 (COVID-19) is one of the current global public health threats and vaccination is the most effective tool to reduce the spread and decrease the severity of COVID-19. Diabetes is one of the important chronic diseases threatening human health and is a common comorbidity of COVID-19. What is the impact of diabetes on the immunization effect of COVID-19 vaccination? Conversely, does vaccination against COVID-19 exacerbate the severity of pre-existing diseases in patients with diabetes? There are limited and conflicting data on the interrelationship between diabetes and COVID-19 vaccination.
    Aim: To explore the clinical factors and possible mechanisms underlying the interaction between COVID-19 vaccination and diabetes.
    Methods: We conducted a comprehensive search of PubMed, MEDLINE, EMBASE, and
    Results: A total of 54 studies were included, from 17 countries. There were no randomized controlled studies. The largest sample size was 350963. The youngest of the included samples was 5 years old and the oldest was 98 years old. The included population included the general population and also some special populations with pediatric diabetes, hemodialysis, solid organ transplantation, and autoimmune diseases. The earliest study began in November 2020. Thirty studies discussed the effect of diabetes on vaccination, with the majority indicating that diabetes reduces the response to COVID-19 vaccination. The other 24 studies were on the effect of vaccination on diabetes, which included 18 case reports/series. Most of the studies concluded that COVID-19 vaccination had a risk of causing elevated blood glucose. A total of 12 of the 54 included studies indicated a "no effect" relationship between diabetes and vaccination.
    Conclusion: There is a complex relationship between vaccination and diabetes with a bidirectional effect. Vaccination may contribute to the risk of worsening blood glucose in diabetic patients and diabetic patients may have a lower antibody response after vaccination than the general population.
    Language English
    Publishing date 2023-06-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2583471-X
    ISSN 1948-9358
    ISSN 1948-9358
    DOI 10.4239/wjd.v14.i6.892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A retrospective analysis of acute kidney injury in children with post-COVID-19 multisystem inflammatory syndrome: insights into promising outcomes.

    El-Halaby, Hanan / Eid, Riham / Elagamy, Ahmed / El-Hussiny, Ahmed / Moustafa, Fatma / Hammad, Ayman / Zeid, Mayada

    Italian journal of pediatrics

    2024  Volume 50, Issue 1, Page(s) 23

    Abstract: ... Between March 2021 and June 2023, a total of 655 confirmed COVID-19 cases were admitted and then followed ... AKI in a formerly healthy kidney, of whom 51% (16 patients) were classified as KDIGO stage 3, 5 ... of AKI in a cohort of Egyptian children with MIS-children (MIS-C) post-COVID infection. Patients were ...

    Abstract Background: Acute kidney injury (AKI) in patients with multisystem inflammatory syndrome (MIS), COVID-19 related infection has been increasingly recognized with a paucity of data on AKI incidence, related mortality, and the requirement of renal replacement therapy in children with MIS (MIS-C).
    Methods: This is a retrospective study evaluating the prevalence, severity, management and outcomes of AKI in a cohort of Egyptian children with MIS-children (MIS-C) post-COVID infection. Patients were included if they met the criteria for MIS-C based on CDC guidelines. All patients were evaluated for AKI diagnosis and staging according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria.
    Results: Between March 2021 and June 2023, a total of 655 confirmed COVID-19 cases were admitted and then followed up in our hospital, of whom 138 (21%) were diagnosed with MIS-C. Fifty-one patients developed AKI associated with MIS-C post-COVID infection, 42 of whom were included in the analysis. Thirty-one patients had AKI in a formerly healthy kidney, of whom 51% (16 patients) were classified as KDIGO stage 3, 5 patients needed hemodialysis and 13 needed mechanical ventilation. Higher WBCs count, and serum ferritin on admission were associated with more severe AKI (KDIGO stage 3) (p = 0.04), while multivariate analysis showed high serum ferritin to be independent predictor of more severe AKI (p = 0.02). Two patients (2/31) died during hospital admission, while no residual renal impairment was reported at the time of discharge of patients with previously normal kidney functions.
    Conclusion: More than one-third of patients with MIS-C develop AKI. Avoidance of nephrotoxic drugs, early recognition, and prompt management of AKI, including well-timed commencement of dialysis in MIS-C cases, is associated with favorable outcomes.
    MeSH term(s) Humans ; Retrospective Studies ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/therapy ; Acute Kidney Injury/diagnosis ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/etiology ; Ferritins ; Hospital Mortality ; Risk Factors ; Systemic Inflammatory Response Syndrome
    Chemical Substances Ferritins (9007-73-2)
    Language English
    Publishing date 2024-02-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 2088556-8
    ISSN 1824-7288 ; 1720-8424
    ISSN (online) 1824-7288
    ISSN 1720-8424
    DOI 10.1186/s13052-024-01598-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: COVID-19 Infection Associated with Psychosis in Hemodialysis Patient.

    Atris, Ahmed / Al Salmi, Issa / Hannawi, Suad

    Oman medical journal

    2021  Volume 36, Issue 5, Page(s) e312

    Abstract: ... than in the general population. We report a rare case of new-onset psychosis (mostly delirium) following COVID-19 infection ... may be less severe in dialysis patients as death due to COVID-19 or effects on comorbidities in COVID-19 ... Moreover, hemodialysis patients constitute a distinct and high-risk group that is often associated with low ...

    Abstract Hemodialysis is a medical procedure to correct electrolyte imbalance and remove fluids and waste products from the blood of patients with end-stage renal disease. Dialysis patients are immunosuppressed and hence at risk of complications of coronavirus infection. In addition, dialysis for most patients is performed in-center, with therapy offered three times per week for 3.5 hours per session in sites highly exposed to virus contamination. A weak immune system and low cytokine storm explain why COVID-19 may be less severe in dialysis patients as death due to COVID-19 or effects on comorbidities in COVID-19 patients is due to overresponse against the virus by the immune system and cytokine storm. However, during the frequent trips between the dialysis center and home, the risk of coronavirus infection could be high. Moreover, hemodialysis patients constitute a distinct and high-risk group that is often associated with low immunity, decline or loss of the ability to work, substantial economic burden, the inability to fulfill family responsibilities and participate in an active social life, and suffer from various complications such as muscle weakness, pruritus, fatigue, diabetes, hypertension, and restless legs. These factors are associated with lower quality of life and poor clinical outcomes, leading to a higher risk of psychological problems than in the general population. We report a rare case of new-onset psychosis (mostly delirium) following COVID-19 infection in a middle-aged hemodialysis patient with rapid recovery.
    Language English
    Publishing date 2021-09-30
    Publishing country Oman
    Document type Case Reports
    ZDB-ID 2571431-4
    ISSN 2070-5204 ; 1999-768X
    ISSN (online) 2070-5204
    ISSN 1999-768X
    DOI 10.5001/omj.2022.38
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Desenlace por COVID-19 en pacientes en hemodiálisis

    Ivonne Reyes Sánchez / Miguel Ángel Rojas Santiago / Miguel Ángel de León García Guerrero / Jesús Manolo Ramos Gordillo / René Patiño Ortega / Eduardo Monsivais Huertero / Oswaldo Sinue Medina Gómez / José Ramón Paniagua Sierra / Juan Carlos H Hernández Rivera

    Medicina Clínica Práctica, Vol 5, Iss 2, Pp 100309- (2022)

    2022  

    Abstract: ... Introduction and objective: The SARS-CoV-2 epidemic represents a special risk for patients on hemodialysis (HD ... de los pacientes en hemodiálisis (HD) que presentaron cuadro sospechoso de COVID-19 (por sus siglas en inglés ... de casos, retrospectivo, observacional, en los pacientes en HD sospechosos de COVID-19. Registrándose ...

    Abstract Resumen: Introducción y objetivo: La epidemia de SARS-CoV-2 representa un riesgo especial para los pacientes en hemodiálisis (HD) por sus comorbilidades, y el cursar con una inflamación más severa con menos síntomas y peor evolución. Nuestro objetivo fue conocer las características clínicas y bioquímicas de los pacientes en hemodiálisis (HD) que presentaron cuadro sospechoso de COVID-19 (por sus siglas en inglés de Corona Virus Disease – 2019), sus factores de riesgo y desenlace. Material y métodos: Estudio de reporte de casos, retrospectivo, observacional, en los pacientes en HD sospechosos de COVID-19. Registrándose comorbilidades, clínica, laboratorio, prueba de transcripción reversa cuantitativa de la reacción en cadena de polimerasa (RT-qPCR) para SARS-COV-2 y desenlace. Se realizó estadística descriptiva y análisis de regresión lineal y logístico. Resultados: De 1.514 personas que recibían tratamiento de HD, 248 pacientes presentaron sintomatología sospechosa de COVID-19 (106 positivos, 83 negativos y 59 sospechosos por PCR), mediana de edad de 51 años (RI 36-63 años), 54,8% masculinos, hipertensión (87,5%), hemoglobina de 8,9 g (RI 7,5-10,6 g); la sintomatología de tos, fiebre y disnea (65,7, 64,5 y 53,2% respectivamente). El porcentaje de letalidad en el grupo de los pacientes con RT-qPCR positiva fue de 29,24%. Conclusiones: La tasa de mortalidad y letalidad es alta en este tipo de población. El grupo etario, el sexo y las comorbilidades cardiometabólicas se comportan similar al resto de la población no renal. El estado bioquímico preexistente no marca una diferencia en el desenlace. La sintomatología predominante es respiratoria. Abstract: Introduction and objective: The SARS-CoV-2 epidemic represents a special risk for patients on hemodialysis (HD) due to their comorbidities and the fact that they often have a more severe case of inflammation with fewer symptoms and a worse evolution and outcome. The aim of this study was to detect the clinical and biochemical characteristics of patients on ...
    Keywords Hemodialysis ; COVID-19 ; Outcome ; Medicine (General) ; R5-920
    Language English
    Publishing date 2022-04-01T00:00:00Z
    Publisher Elsevier España
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: COVID-19-related clinical outcomes among Korean hemodialysis patients.

    Park, Hayne Cho / Lee, Young-Ki / Ko, Eunsil / Yu, Sungbong / Cho, AJin / Kim, Do Hyoung / Kim, Jinseog / Cho, Jang-Hee / Lee, Jeonghwan / Kim, Dong Ki / Kim, Seong Nam / Yang, Chul-Woo

    Kidney research and clinical practice

    2022  Volume 41, Issue 5, Page(s) 591–600

    Abstract: ... Task Force Team collected clinical data for HD patients with confirmed COVID-19 via a self-report survey ... COVID-19) confirmed Korean HD patients.: Methods: From February 2020 to November 2021, the COVID-19 ... among HD patients and compared to those of individuals without CKD using the COVID-19 database ...

    Abstract Background: Hemodialysis (HD) patients are more vulnerable to viral epidemics, experiencing higher mortality rates compared to individuals without chronic kidney disease (CKD). This retrospective cohort study sought to demonstrate clinical outcomes and associated factors among coronavirus disease 2019 (COVID-19) confirmed Korean HD patients.
    Methods: From February 2020 to November 2021, the COVID-19 Task Force Team collected clinical data for HD patients with confirmed COVID-19 via a self-report survey of nephrologists. The composite outcome included in-hospital mortality, admission to the intensive care unit (ICU), and use of mechanical ventilation. Risk factors associated with clinical outcomes were analyzed among HD patients and compared to those of individuals without CKD using the COVID-19 database from the Korea Disease Control and Prevention Agency.
    Results: A total of 380 HD patients from 206 facilities were diagnosed with COVID-19. Fever (49.5%) and cough (25.7%) were the two most common initial symptoms. The overall in-hospital fatality rate was 22.4% and even higher among ICU admission cases (64.7%). Non-survivors were older, more frequently developed shortness of breath, and were more likely to come from a nursing hospital. Compared to the age- and sex-matched non-CKD population, HD patients showed greater risk of in-hospital mortality (hazard ratio, 2.07; 95% confidence interval, 1.56-2.75; p < 0.001) and composite outcome (hazard ratio, 3.50; 95% confidence interval, 2.56-4.77; p < 0.001).
    Conclusion: HD patients have a greater risk of in-hospital mortality and morbidity from COVID-19. Special attention should be paid to COVID-19 HD patients when they are older or present with symptoms.
    Language English
    Publishing date 2022-06-21
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2656420-8
    ISSN 2211-9132
    ISSN 2211-9132
    DOI 10.23876/j.krcp.22.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: New Onset Biopsy-Proven Nephropathies after COVID Vaccination.

    Fenoglio, Roberta / Lalloni, Stefania / Marchisio, Martina / Oddone, Valentina / De Simone, Emanuele / Del Vecchio, Giulio / Sciascia, Savino / Roccatello, Dario

    American journal of nephrology

    2022  Volume 53, Issue 4, Page(s) 325–330

    Abstract: ... was the most common disease in our cohort (5 patients, 29.4%) followed by acute ... 47.1%) developed acute kidney injury. Two patients with acute TIN had to start hemodialysis that was ... we hypothesize that the immune response to the COVID-19 vaccine may be a trigger of nephropathies ...

    Abstract Introduction: To date, almost 7 billion doses of the different types of vaccine against SARS-CoV-2 have been administered worldwide. Although the severity of new cases of SARS-CoV-2 has progressively decreased, and the pressure on national health systems has declined, the development of de novo glomerular injuries has been suggested.
    Methods: This study aimed to examine the patients who were hospitalized in our Unit between April and November 2021 and underwent renal biopsy for new-onset urinary abnormalities (UA) and/or renal impairment within 3 months of SARS-CoV-2 vaccination.
    Results: We identified 17 patients who developed UA and/or renal insufficiency within 3 months of vaccination. Minimal change disease was the most common disease in our cohort (5 patients, 29.4%) followed by acute tubulointerstitial nephritis (TIN; 3 patients, 17.6%), membranous nephropathy (3 patients, 17.6%), and rapidly progressive IgA nephropathy (2 patients, 11.8%). The other 4 patients had a diagnosis of membranoproliferative glomerulonephritis (1 patient), systemic lupus erythematosus (1 patient), ANCA-associated vasculitis (1 patient), and tip-variant focal segmental glomerulosclerosis (1 patient), respectively. Eight out of the 17 patients (47.1%) developed acute kidney injury. Two patients with acute TIN had to start hemodialysis that was discontinued after 1 and 2 months, respectively, due to the recovery of renal function. All patients underwent treatment with corticosteroids and/or immunosuppressants.
    Discussion: Although it is not possible to conclusively determine whether there is a causal relationship between SARS-CoV-2 vaccination and new-onset nephropathies, based on the appearance of UA and/or renal insufficiency shortly after vaccination, we hypothesize that the immune response to the COVID-19 vaccine may be a trigger of nephropathies. Therefore, our results highlight the need for pharmacovigilance. However, this report should not lead to vaccine hesitation during this pandemic as the benefits of vaccination strongly outweigh the potential risks.
    MeSH term(s) Female ; Humans ; Male ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/etiology ; Biopsy ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Glomerulonephritis, IGA/pathology ; SARS-CoV-2 ; Vaccination/adverse effects
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2022-03-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 604540-6
    ISSN 1421-9670 ; 0250-8095
    ISSN (online) 1421-9670
    ISSN 0250-8095
    DOI 10.1159/000523962
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant.

    Pinte, Larisa / Sorohan, Bogdan Marian / Prohászka, Zoltán / Gherghiceanu, Mihaela / Băicuş, Cristian

    Romanian journal of internal medicine = Revue roumaine de medecine interne

    2022  Volume 60, Issue 2, Page(s) 138–142

    Abstract: ... 2019 (COVID-19) in patients with complement gene mutations as a cause of acute kidney injury (AKI) are ... modifiers in the alternative pathway dysregulation of the complement in the setting of COVID-19, even ... limited. We presented the case of a 23-year-old male patient admitted with an asymptomatic form of COVID ...

    Abstract The evidence regarding thrombotic microangiopathy (TMA) related to Coronavirus Infectious Disease 2019 (COVID-19) in patients with complement gene mutations as a cause of acute kidney injury (AKI) are limited. We presented the case of a 23-year-old male patient admitted with an asymptomatic form of COVID-19, but with uncontrolled hypertension and AKI. Kidney biopsy showed severe lesions of TMA. In evolution patient had persistent microangiopathic hemolytic anemia, decreased level of haptoglobin and increased LDH level. Decreased complement C3 level and the presence of schistocytes were found for the first time after biopsy. Kidney function progressively decreased and the patient remained hemodialysis dependent. Complement work-up showed a heterozygous variant with unknown significance in complement factor I (CFI) c.-13G>A, affecting the 5' UTR region of the gene. In addition, the patient was found to be heterozygous for the complement factor H (CFH) H3 haplotype (involving the rare alleles of c.-331C>T, Q672Q and E936D polymorphisms) reported as a risk factor of atypical hemolytic uremic syndrome. This case of AKI associated with severe TMA and secondary hemolytic uremic syndrome highlights the importance of genetic risk modifiers in the alternative pathway dysregulation of the complement in the setting of COVID-19, even in asymptomatic forms.
    MeSH term(s) Acute Kidney Injury/complications ; Adult ; Atypical Hemolytic Uremic Syndrome/complications ; Atypical Hemolytic Uremic Syndrome/genetics ; COVID-19/complications ; Communicable Diseases/complications ; Humans ; Male ; Thrombotic Microangiopathies/genetics ; Young Adult
    Language English
    Publishing date 2022-06-14
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 2015966-3
    ISSN 2501-062X ; 0035-3973 ; 1582-3296
    ISSN (online) 2501-062X
    ISSN 0035-3973 ; 1582-3296
    DOI 10.2478/rjim-2021-0040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: COVID-19 in Hemodialysis Patients

    Wang, Rui / Liao, Cong / He, Hong / Hu, Chun / Wei, Zimeng / Hong, Zixi / Zhang, Chengjie / Liao, Meiyan / Shui, Hua

    American Journal of Kidney Diseases

    A Report of 5 Cases

    2020  Volume 76, Issue 1, Page(s) 141–143

    Keywords Nephrology ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1053/j.ajkd.2020.03.009
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top